相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α
Marie-Cecile Valera et al.
BLOOD (2012)
Further Evidence of the Clinical, Hormonal, and Genetic Heterogeneity of Klinefelter Syndrome: A Study of 216 Infertile Egyptian Patients
Moheb M. Abdel-Razic et al.
JOURNAL OF ANDROLOGY (2012)
Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
Clinical trials in male hormonal contraception
Eberhard Nieschlag
CONTRACEPTION (2010)
17α-Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor α
A. C. A. Cleuren et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study
Johan Svartberg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Elevated Plasma YKL-40 Predicts Increased Risk of Gastrointestinal Cancer and Decreased Survival After Any Cancer Diagnosis in the General Population
Julia S. Johansen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Study of adverse outcomes in women using testosterone therapy
T. P. van Staa et al.
MATURITAS (2009)
Hormonal contraception and risk of venous thromboembolism: national follow-up study
Ojvind Lidegaard et al.
BRITISH MEDICAL JOURNAL (2009)
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population
Pia R. Kamstrup et al.
CIRCULATION (2008)
Pulmonary embolism associated with the use of anabolic steroids
Sissela Liljeqvist et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2008)
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Borge G. Nordestgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells
Hong Jin et al.
BIOCHEMISTRY AND CELL BIOLOGY (2007)
Experimental arterial thrombosis regulated by androgen and its receptor via modulation of platelet activation
ShiJun Li et al.
THROMBOSIS RESEARCH (2007)
Venous thromboembolism: disease burden, outcomes and risk factors
JA Heit
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy - A clinical review
MPV Gomes et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men
C Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The epidemiology of venous thromboembolism
RH White
CIRCULATION (2003)
Estrogen administration enhances thrombin generation in rats
R Ohashi et al.
THROMBOSIS RESEARCH (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Noncardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II)
S Hulley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study
D Grady et al.
ANNALS OF INTERNAL MEDICINE (2000)
分享论文
